PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 160 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $3,124,000 | -51.0% | 58,965 | -28.7% | 0.01% | -54.5% |
| Q4 2015 | $6,371,000 | +1836.5% | 82,720 | +934.0% | 0.01% | +1000.0% |
| Q3 2015 | $329,000 | -91.6% | 8,000 | -81.9% | 0.00% | -85.7% |
| Q1 2015 | $3,926,000 | -52.2% | 44,195 | -52.4% | 0.01% | -50.0% |
| Q4 2014 | $8,210,000 | -17.7% | 92,842 | -9.8% | 0.01% | -22.2% |
| Q3 2014 | $9,974,000 | -11.0% | 102,911 | -15.7% | 0.02% | -10.0% |
| Q2 2014 | $11,213,000 | +39.5% | 122,071 | +6.3% | 0.02% | +42.9% |
| Q1 2014 | $8,036,000 | +59.2% | 114,827 | +55.3% | 0.01% | +55.6% |
| Q4 2013 | $5,048,000 | +74.8% | 73,959 | +23.2% | 0.01% | +80.0% |
| Q3 2013 | $2,888,000 | +76.9% | 60,046 | +6.6% | 0.01% | +66.7% |
| Q2 2013 | $1,633,000 | – | 56,317 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Doma Perpetual Capital Management LLC | 1,000,761 | $28,631,772 | 13.28% |
| GAGNON SECURITIES LLC | 596,591 | $17,068,469 | 3.84% |
| Sio Capital Management, LLC | 455,500 | $13,031,855 | 3.53% |
| Gagnon Advisors, LLC | 133,390 | $3,816,288 | 2.91% |
| AlphaCentric Advisors LLC | 117,500 | $3,361,675 | 2.48% |
| ARDSLEY ADVISORY PARTNERS LP | 580,000 | $16,593,800 | 2.44% |
| RICE HALL JAMES & ASSOCIATES, LLC | 998,625 | $28,570,661 | 1.71% |
| Lisanti Capital Growth, LLC | 138,830 | $3,971,926 | 0.96% |
| Bridge City Capital, LLC | 84,856 | $2,427,730 | 0.82% |
| Rock Springs Capital Management LP | 785,000 | $22,458,850 | 0.68% |